152 related articles for article (PubMed ID: 20652713)
21. Use of a newly-developed portable capillary electrophoresis analyser to detect drugs of abuse in oral fluid: A case study.
Saar-Reismaa P; Brilla CA; Leiman K; Kaljurand M; Vaher M; Kulp M; Mazina-Šinkar J
Talanta; 2020 May; 211():120662. PubMed ID: 32070623
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of RapidSTAT®, DrugWipe® 6S, DrugScreen® 5TK and DrugScreen® 7TR for on-site drug testing in German police roadside traffic patrol.
Liut J; Bott U; Madea B; Krämer M; Maas A
Drug Test Anal; 2022 Aug; 14(8):1407-1416. PubMed ID: 35343088
[TBL] [Abstract][Full Text] [Related]
23. Laboratory evaluation and field application of roadside oral fluid collectors and drug testing devices.
Crouch DJ; Walsh JM; Cangianelli L; Quintela O
Ther Drug Monit; 2008 Apr; 30(2):188-95. PubMed ID: 18367979
[TBL] [Abstract][Full Text] [Related]
24. On-site testing of illicit drugs: the use of the drug-testing device "Toxiquick".
Biermann T; Schwarze B; Zedler B; Betz P
Forensic Sci Int; 2004 Jun; 143(1):21-5. PubMed ID: 15177627
[TBL] [Abstract][Full Text] [Related]
25. Opioids in oral fluid of Spanish drivers.
Herrera-Gómez F; García-Mingo M; Colás M; González-Luque JC; Álvarez FJ
Drug Alcohol Depend; 2018 Jun; 187():35-39. PubMed ID: 29626744
[TBL] [Abstract][Full Text] [Related]
26. Detection of Δ
Arkell TR; Kevin RC; Stuart J; Lintzeris N; Haber PS; Ramaekers JG; McGregor IS
Drug Test Anal; 2019 Oct; 11(10):1486-1497. PubMed ID: 31442003
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of three rapid oral fluid test devices on the screening of multiple drugs of abuse including ketamine.
Tang MHY; Ching CK; Poon S; Chan SSS; Ng WY; Lam M; Wong CK; Pao R; Lau A; Mak TWL
Forensic Sci Int; 2018 May; 286():113-120. PubMed ID: 29574346
[TBL] [Abstract][Full Text] [Related]
28. A placebo-controlled study to assess Standardized Field Sobriety Tests performance during alcohol and cannabis intoxication in heavy cannabis users and accuracy of point of collection testing devices for detecting THC in oral fluid.
Bosker WM; Theunissen EL; Conen S; Kuypers KP; Jeffery WK; Walls HC; Kauert GF; Toennes SW; Moeller MR; Ramaekers JG
Psychopharmacology (Berl); 2012 Oct; 223(4):439-46. PubMed ID: 22581391
[TBL] [Abstract][Full Text] [Related]
29. Roche DAT immunoassay: sensitivity and specificity testing for amphetamines, cocaine, and opiates in oral fluid.
Crooks CR; Brown S
J Anal Toxicol; 2010 Mar; 34(2):103-9. PubMed ID: 20223103
[TBL] [Abstract][Full Text] [Related]
30. Analytical evaluation of four on-site oral fluid drug testing devices.
Vanstechelman S; Isalberti C; Van der Linden T; Pil K; Legrand SA; Verstraete AG
J Anal Toxicol; 2012 Mar; 36(2):136-40. PubMed ID: 22337784
[TBL] [Abstract][Full Text] [Related]
31. Identification and quantitation of amphetamines, cocaine, opiates, and phencyclidine in oral fluid by liquid chromatography-tandem mass spectrometry.
Fritch D; Blum K; Nonnemacher S; Haggerty BJ; Sullivan MP; Cone EJ
J Anal Toxicol; 2009; 33(9):569-77. PubMed ID: 20040131
[TBL] [Abstract][Full Text] [Related]
32. Driving under the influence of drugs--amphetamine concentrations in oral fluid and whole blood samples.
Engblom C; Gunnar T; Rantanen A; Lillsunde P
J Anal Toxicol; 2007 Jun; 31(5):276-80. PubMed ID: 17579972
[TBL] [Abstract][Full Text] [Related]
33. Detection of cannabis use in drivers with the drugwipe device and by GC-MS after Intercept device collection.
Kintz P; Bernhard W; Villain M; Gasser M; Aebi B; Cirimele V
J Anal Toxicol; 2005 Oct; 29(7):724-7. PubMed ID: 16419408
[TBL] [Abstract][Full Text] [Related]
34. Detection of drugs of abuse in simultaneously collected oral fluid, urine and blood from Norwegian drug drivers.
Vindenes V; Lund HM; Andresen W; Gjerde H; Ikdahl SE; Christophersen AS; Øiestad EL
Forensic Sci Int; 2012 Jun; 219(1-3):165-71. PubMed ID: 22284072
[TBL] [Abstract][Full Text] [Related]
35. Optimization and validation of CEDIA drugs of abuse immunoassay tests in serum on Hitachi 912.
Kirschbaum KM; Musshoff F; Schmithausen R; Stockhausen S; Madea B
Forensic Sci Int; 2011 Oct; 212(1-3):252-5. PubMed ID: 21775079
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of Dräger DrugTest 5000 in a Naturalistic Setting.
Gjerde H; Clausen GB; Andreassen E; Furuhaugen H
J Anal Toxicol; 2018 May; 42(4):248-254. PubMed ID: 29409046
[TBL] [Abstract][Full Text] [Related]
37. The utility of delta 9-tetrahydrocannabinol (THC) measures obtained from oral fluid samples in traffic safety.
Romano E; Moore C; Kelley-Baker T; Torres-Saavedra PA
Traffic Inj Prev; 2019; 20(7):667-672. PubMed ID: 31356118
[No Abstract] [Full Text] [Related]
38. Optimization of cloned enzyme donor immunoassay cut-offs for drugs of abuse in whole blood of drivers involved in road accidents.
Pelletti G; Garagnani M; Rossi F; Roffi R; Barone R; Pelotti S
Forensic Sci Int; 2019 Jan; 294():27-33. PubMed ID: 30447484
[TBL] [Abstract][Full Text] [Related]
39. Detection of Drugs in Oral Fluid Samples Using a Commercially Available Collection Device: Agreement with Urine Testing and Evaluation of A and B Samples Obtained from Employees at Different Workplace Settings with Uncontrolled Sampling Procedures.
Zheng Y; Sparve E; Sparring S; Bergström M
J Anal Toxicol; 2021 Jan; 44(9):1004-1011. PubMed ID: 32128555
[TBL] [Abstract][Full Text] [Related]
40. Surveillance by oral fluid of drugs subject to misuse among individuals under arrest.
Magura S; Weller BE; Smith DR; Saxton MM; Amaratunga P
Am J Drug Alcohol Abuse; 2021 Mar; 47(2):247-254. PubMed ID: 33481634
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
